These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7010291)
1. Residual beta-cell function and islet cell antibodies in diabetic children. Crossley JR; James AG; Elliot RB; Berryman CC; Edgar BW Pediatr Res; 1981 Jan; 15(1):62-5. PubMed ID: 7010291 [No Abstract] [Full Text] [Related]
2. Islet-cell antibodies and beta-cell function in insulin-dependent diabetics. Madsbad S; Bottazzo GF; Cudworth AG; Dean B; Faber OK; Binder C Diabetologia; 1980 Jan; 18(1):45-7. PubMed ID: 6988264 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic islet cell and thyroid antibodies, and islet cell function in diabetic patients of Mexican-American origin. Zeidler A; Frasier SD; Penny R; Stein RB; Nicoloff JT J Clin Endocrinol Metab; 1982 May; 54(5):949-54. PubMed ID: 7037824 [No Abstract] [Full Text] [Related]
4. Islet function in diabetics with persistent islet cell antibodies. Theophanides CG; Pyke DA; Watkins PJ Diabetes; 1978; 27 Suppl 1():265-6. PubMed ID: 344118 [TBL] [Abstract][Full Text] [Related]
5. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old. Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592 [TBL] [Abstract][Full Text] [Related]
6. [Functional study of pancreatic islets altered by the autoimmune system in diabetic and non-diabetic subjects]. Tiengo A; Del Prete G; Nosadini R Journ Annu Diabetol Hotel Dieu; 1977; ():119-33. PubMed ID: 330918 [No Abstract] [Full Text] [Related]
7. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390 [TBL] [Abstract][Full Text] [Related]
8. [Secondary failure to oral hypoglycemic drugs: islet cell function determined by urinary C-peptide]. Durruty P; García de los Rios M; López G Rev Med Chil; 1988 Apr; 116(4):301-7. PubMed ID: 3072638 [No Abstract] [Full Text] [Related]
9. Factors of importance for residual beta-cell function in type I diabetes mellitus. A review. Madsbad S Acta Med Scand Suppl; 1983; 671():61-7. PubMed ID: 6349267 [No Abstract] [Full Text] [Related]
10. Islet cell cytoplasmic and cell surface antibodies in diabetes mellitus. Freedman ZR; Feek CM; Irvine WJ; Lernmark A; Rubenstein AH; Steiner DF; Huen A Trans Assoc Am Physicians; 1979; 92():64-76. PubMed ID: 398630 [No Abstract] [Full Text] [Related]
11. Residual pancreatic function in insulin dependent diabetics. Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357 [TBL] [Abstract][Full Text] [Related]
12. [Functional activity of the insular apparatus of the pancreas in children with newly diagnosed diabetes mellitus]. Shcherbacheva LN; Lobanova AM; Arbuzova MI Pediatriia; 1989; (11):10-4. PubMed ID: 2691976 [TBL] [Abstract][Full Text] [Related]
13. Complement-fixing islet-cell antibodies in type I diabetes and in susceptible patients with autoimmune diseases. Betterle C; Caretto A; Tiengo A; Trevisan A Lancet; 1980 Jun; 1(8183):1418-9. PubMed ID: 6104205 [No Abstract] [Full Text] [Related]
14. European Association for the Study of Diabetes Annual Meeting, 1999: the beta-cell, autoimmunity, and insulin resistance. Bloomgarden ZT Diabetes Care; 2000 Aug; 23(8):1192-6. PubMed ID: 10937521 [No Abstract] [Full Text] [Related]
15. Residual B cell function in diabetic children as determined by urinary C-peptide. Aurbach-Klipper J; Sharph-Dor R; Heding LG; Karp M; Laron Z Diabetologia; 1983 Feb; 24(2):88-90. PubMed ID: 6341140 [TBL] [Abstract][Full Text] [Related]
16. Prospective study of predictors of beta-cell survival in type I diabetes. Schiffrin A; Suissa S; Poussier P; Guttmann R; Weitzner G Diabetes; 1988 Jul; 37(7):920-5. PubMed ID: 3290010 [TBL] [Abstract][Full Text] [Related]
17. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing residual pancreatic beta cell function in recently diagnosed Type 1 diabetic children. Hill MA; Court JM Aust Paediatr J; 1982 Mar; 18(1):37-9. PubMed ID: 7049145 [No Abstract] [Full Text] [Related]
19. Detection of antibodies to islet cells and insulin with paraffin-embedded pancreas as antigen. Dobersen MJ; Bell AM; Jenson AB; Notkins AL; Ginsberg-Fellner F Lancet; 1979 Nov; 2(8151):1078. PubMed ID: 91817 [No Abstract] [Full Text] [Related]
20. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies. Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]